共 27 条
Optical Coherence Tomographic Observation of In-Stent Neoatherosclerosis in Lesions With More Than 50% Neointimal Area Stenosis After Second-Generation Drug-Eluting Stent Implantation
被引:73
作者:
Lee, Seung-Yul
[1
]
Hur, Seung-Ho
[2
]
Lee, Sang-Gon
[3
]
Kim, Sang-Wook
[4
]
Shin, Dong-Ho
[5
,6
]
Kim, Jung-Sun
[5
,6
]
Kim, Byeong-Keuk
[5
,6
]
Ko, Young-Guk
[5
,6
]
Choi, Donghoon
[5
,6
]
Jang, Yangsoo
[5
,6
,7
]
Hong, Myeong-Ki
[5
,6
,7
]
机构:
[1] Int St Marys Hosp, Dept Cardiol, Inchon, South Korea
[2] Keimyung Univ, Dept Cardiol, Coll Med, Taegu, South Korea
[3] Univ Ulsan, Coll Med, Dept Cardiol, Ulsan 680749, South Korea
[4] Chung Ang Univ, Med Ctr, Dept Cardiol, Seoul 156756, South Korea
[5] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Cardiovasc Inst, Seoul, South Korea
[7] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea
关键词:
atherosclerosis;
drug-eluting stent;
optical coherence tomography;
BARE-METAL STENTS;
MYOCARDIAL-INFARCTION;
RESTENOSIS;
THROMBOSIS;
PATHOLOGY;
DISEASE;
ATHEROSCLEROSIS;
REGISTRY;
RISK;
D O I:
10.1161/CIRCINTERVENTIONS.114.001878
中图分类号:
R5 [内科学];
学科分类号:
100201 [内科学];
摘要:
Background-Despite the enhanced properties of the second-generation drug-eluting stent (DES), its association with neoatherosclerosis has not been sufficiently evaluated. Therefore, we sought to evaluate and compare neoatherosclerosis in second-generation DESs to first-generation DESs. Methods and Results-A total of 212 DES-treated patients with >50% percent neointimal cross-sectional area stenosis were retrospectively enrolled from the Korean multicenter optical coherence tomography (OCT) registry. Within this population, 111 patients had a second-generation DES (40 zotarolimus, 36 everolimus, and 35 biolimus) and 101 patients had a first-generation (65 sirolimus and 36 paclitaxel) DES. Neoatherosclerosis on OCT was defined as neointima formation with the presence of lipids or calcification. OCT-determined neoatherosclerosis was identified in 27.4% (58/212) of all DES-treated lesions. The frequency of neoatherosclerosis increased with the stent age. Stent age was shorter in the second-generation DES group (12.4 months versus 55.4 months, P<0.001), and neoatherosclerosis was less frequently observed in that group (10.8% versus 45.5%, P<0.001). However, after adjusting for cardiovascular risk factors, chronic kidney disease (odds ratio, 4.113; 95% confidence interval, 1.086-15.575; P=0.037), >70 mg/dL of low-density cholesterol at follow-up OCT (odds ratio, 2.532; 95% confidence interval, 1.054-6.084; P=0.038), and stent age (odds ratio, 1.710; 95% confidence interval, 1.403-2.084; P<0.001) were all independent predictors for neoatherosclerosis, whereas the type of DES (first-versus second-generation) was not. Patients with neoatherosclerosis showed a higher rate of acute coronary syndrome at follow-up OCT (19.0% versus 3.9%, respectively, P=0.001). Conclusions-The second-generation DES is not more protective against neoatherosclerosis compared with the first-generation DES.
引用
收藏
页数:9
相关论文

